It was reported that the patient had an initial procedure on (b)(6) 2013 with a bifurcated and suprarenal aortic extension.Subsequently, on (b)(6) 2016, the patient present to the hospital with a rupture and type 3a endoleak.Physician implanted a non-endologix graft to repair the issue.Patient is in stable condition.
|
At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm; a type 3 endoleak between the main body and the proximal extension and an aneurysm rupture.There was also evidence to reasonable suggest the following observations; a type 1a endoleak, aneurysm sac growth, suboptimal overlap between the main body and proximal extension, and dilation of the main body stent.The clinical evaluation additionally identified the following potential contributing factors to the reported event; off label use due to patient anatomy, insufficient overlap between the main body and the proximal extension, and the patient's history of cardiac disease.The review of the manufacturing lot confirmed all devices met specifications prior to release.The event devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.
|